These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 16000240

  • 21. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium.
    Henry DA, Campbell ME, LiPuma JJ, Speert DP.
    J Clin Microbiol; 1997 Mar; 35(3):614-9. PubMed ID: 9041399
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. PCR-based identification and characterization of Burkholderia cepacia complex bacteria from clinical and environmental sources.
    Seo ST, Tsuchiya K.
    Lett Appl Microbiol; 2004 Mar; 39(5):413-9. PubMed ID: 15482431
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Risk factors for Burkholderia cepacia complex colonization and infection among patients with cystic fibrosis.
    Walsh NM, Casano AA, Manangan LP, Sinkowitz-Cochran RL, Jarvis WR.
    J Pediatr; 2002 Oct; 141(4):512-7. PubMed ID: 12378190
    [Abstract] [Full Text] [Related]

  • 27. Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.
    Vanlaere E, Baldwin A, Gevers D, Henry D, De Brandt E, LiPuma JJ, Mahenthiralingam E, Speert DP, Dowson C, Vandamme P.
    Int J Syst Evol Microbiol; 2009 Jan; 59(Pt 1):102-11. PubMed ID: 19126732
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Evaluation of restriction fragment length polymorphism analysis of 16S rDNA as a tool for genomovar characterisation within the Burkholderia cepacia complex.
    Vermis K, Vandekerckhove C, Nelis HJ, Vandamme PA.
    FEMS Microbiol Lett; 2002 Aug 27; 214(1):1-5. PubMed ID: 12204364
    [Abstract] [Full Text] [Related]

  • 30. Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools.
    Vandamme P, Henry D, Coenye T, Nzula S, Vancanneyt M, LiPuma JJ, Speert DP, Govan JR, Mahenthiralingam E.
    FEMS Immunol Med Microbiol; 2002 Jun 03; 33(2):143-9. PubMed ID: 12052570
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Overrepresentation of immunostimulatory CpG motifs in Burkholderia genomes.
    Coenye T, Vandamme P.
    J Cyst Fibros; 2005 Sep 03; 4(3):193-6. PubMed ID: 15963770
    [Abstract] [Full Text] [Related]

  • 33. Misidentification of a genomovar of Burkholderia cepacia by recA restriction fragment length polymorphism.
    Moore JE, Millar BC, Xu J, Crowe M, Redmond AO, Elborn JS.
    J Clin Pathol; 2002 Apr 03; 55(4):309-11. PubMed ID: 11919219
    [Abstract] [Full Text] [Related]

  • 34. Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods.
    van Pelt C, Verduin CM, Goessens WH, Vos MC, Tümmler B, Segonds C, Reubsaet F, Verbrugh H, van Belkum A.
    J Clin Microbiol; 1999 Jul 03; 37(7):2158-64. PubMed ID: 10364579
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of species-specific recA PCR tests in the identification of Burkholderia cepacia complex environmental isolates.
    Dalmastri C, Pirone L, Tabacchioni S, Bevivino A, Chiarini L.
    FEMS Microbiol Lett; 2005 May 01; 246(1):39-45. PubMed ID: 15869960
    [Abstract] [Full Text] [Related]

  • 36. Isolation and identification of Burkholderia cepacia by participants in an external Quality Assurance Program (QAP) between 1994 and 1999.
    Taylor PC, McLaws ML, De Borde M, Pritchard R.
    Pathology; 2004 Aug 01; 36(4):352-7. PubMed ID: 15370136
    [Abstract] [Full Text] [Related]

  • 37. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis.
    Reik R, Spilker T, Lipuma JJ.
    J Clin Microbiol; 2005 Jun 01; 43(6):2926-8. PubMed ID: 15956421
    [Abstract] [Full Text] [Related]

  • 38. Rapid characterization of the genomovars of the Burkholderia cepacia complex by PCR-single-stranded conformational polymorphism (PCR-SSCP) analysis.
    Moore JE, Millar BC, Jiru X, McCappin J, Crowe M, Elborn JS.
    J Hosp Infect; 2001 Jun 01; 48(2):129-34. PubMed ID: 11428880
    [Abstract] [Full Text] [Related]

  • 39. Isolation of Burkholderia cepacia complex genomovars from waters.
    Vermis K, Brachkova M, Vandamme P, Nelis H.
    Syst Appl Microbiol; 2003 Nov 01; 26(4):595-600. PubMed ID: 14666988
    [Abstract] [Full Text] [Related]

  • 40. Pseudomonas (Burkholderia) cepacia in children with cystic fibrosis: epidemiological investigation by analysis or restriction fragment length polymorphism.
    Valcin M, Moissenet D, Sardet A, Tournier G, Garbarg-Chenon A, Vu-Thien H.
    Pathol Biol (Paris); 1996 May 01; 44(5):442-6. PubMed ID: 8758491
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.